Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Primary Objectives:
1. Assess whether combined treatment with Levothyroxine and Liothyronine improves learning
and memory.
2. Explore the relationship between T3 treatment and other domains of cognitive function,
quality of life, and mood.